読み込み中
NASDAQHealthcareMedical - Healthcare Information Services
最新データ
$14.42
+$0.37 · +2.63%
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
前日終値
$14.42
+$0.37 · +2.63%
日中の時刻はETです。市場データは遅延する場合があります。
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
日中レンジ
現在 $14.42
52週レンジ
現在 $14.42
日中の時刻はETです。市場データは遅延する場合があります。
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
日中レンジ
現在 $14.42
52週レンジ
現在 $14.42
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 |
|---|---|---|---|
| 売上高 | 5051.1万 USD | 2716.5万 USD | 1377.8万 USD |
| 売上原価 | 1247.1万 USD | 711.7万 USD | 387.5万 USD |
| 粗利益 | 3804万 USD | 2004.8万 USD | 990.3万 USD |
| 研究開発 | 1701.9万 USD | 1430.4万 USD | 739.5万 USD |
| 販売・一般管理 | 5159.5万 USD | 2986.6万 USD | 2109.9万 USD |
| 営業費用 | 6861.4万 USD | 4417万 USD | 2849.4万 USD |
| 受取利息 | 269.8万 USD | 133万 USD | 33.4万 USD |
| 支払利息 | 143万 USD | 132.1万 USD | 64.1万 USD |
| 減価償却費と償却費 | 28.1万 USD | 14.5万 USD | 13.6万 USD |
| 営業利益 | −3057.4万 USD | −2412.2万 USD | −1859.1万 USD |
| 純利益 | −2963.4万 USD | −2425.7万 USD | −1889.8万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$18.50
上昇余地（28.29%）この株式へのエクスポージャーを報告している上場投資信託です。
iShares Russell 2000 ETFIWM305.95万0.00%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI258.33万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF127.42万0.00%954億 USD0.05%$235+0.80%
Vanguard Russell 2000 ETFVTWO79.61万0.00%180億 USD0.06%$112.66+0.50%
iShares Russell 2000 Growth ETFIWO61.44万0.00%139.17億 USD0.24%$356.78+0.94%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM46万0.39%1.17億 USD0.73%$15.9402+0.25%
iShares Micro-Cap ETFIWC37.73万0.03%13.17億 USD0.60%$183+0.11%
Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSC7.55万0.09%8141.32万 USD0.69%$36.3803+0.39%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOiShares Russell 2000 Growth ETFIWOEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMiShares Micro-Cap ETFIWCRussell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
